Dr. Anuja Mehta's practice involves domestic and foreign patent portfolio development, management, and enforcement in various areas of life sciences including molecular and cellular biology, antibody therapeutics, pharmaceuticals, cell therapies, vaccines, and microbial biology.
Anuja advises clients regarding patentability, validity, infringement, and freedom-to-operate issues and performs due diligence evaluations of patent portfolios in connection with venture capital and private equity financings, collaborations, and/or partnering deals.
Her practice also includes various post-grant proceedings before the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office (USPTO), including inter partes reviews (IPRs).
Her current representative clients include Janssen Biotech, Merck, Epic Sciences, and Bellicum Pharmaceuticals, as well as other start-up companies, established companies, academic institutions, and investment firms.
Prior to joining Jones Day in 2016, Anuja obtained her Ph.D. in molecular and cell biology in the lab of Prof. James E. Haber at Brandeis University. She has authored several peer-reviewed publications and has served in several leadership roles throughout her academic studies.
Homology Requirements and Competition between Gene Conversion and Break-Induced Replication during Double-Strand Break Repair, Molecular Cell, 65(3):515-526
Sgs1 and Mph1 Helicases Enforce the Recombination Execution Checkpoint During DNA Double-Strand Break Repair in Saccharomyces cerevisiae, Genetics, 203(2):667-75
Sources of DNA double-strand breaks and models of recombinational DNA repair, Cold Springs Harb Perstect Biol., 7;6(9):a016428
Analysis of post-operative changes in serum protein expression profiles from colorectal cancer patients by MALDI-TOF mass spectrometry: a pilot methodological study, World J Surj Oncol., 26;8:33
Ferritin accumulation under iron scarcity in Drosophila iron cells, Biochemie, 91(10):1331-4
Genetic screening for novel Drosophila mutants with discrepancies in iron metabolism, Bichem Soc Trans, 36(Pt 6):1313-6
- University of San Diego (J.D. 2020); Brandeis University (Ph.D. in Molecular and Cell Biology, January 2016; M.S. in Molecular and Cell Biology 2012); University of Essex, England (M.Sc. in Biotechnology with distinction 2007); M.G. Science Institute, Gujarat University, India (B.Sc. in Biochemistry with Biotechnology 2006; Class Valedictorian; University Gold Medalist [achieved top score in university; equivalent to summa cum laude])
- California and registered to practice before the United States Patent and Trademark Office